This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sedjo, R. L. Articles by Giuliano, A. R. Search for Related Content PubMed PubMed Citation Articles by Sedjo, R. L. Articles by Giuliano, A. R.

Circulating Endogenous Retinoic Acid Concentrations among Participants Enrolled in a Randomized Placebo-Controlled Clinical Trial of Retinyl Palmitate

¹ Arizona Cancer Center and ² Arizona College of Public Health, University of Arizona, Tucson, Arizona; ³ Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; and ⁴ Craft Technologies, Inc., Wilson, North Carolina

Requests for reprints: Anna R. Giuliano, H. Lee Moffitt Cancer Center & Research Inst., MRC 2 East Room 2067, 12902 Magnolia Drive, Tampa, FL 33612-9497. Phone: 813-903-6820; Fax: 813-745-6506. E-mail: giuliano{at}moffitt.usf.edu

Retinoids have been studied extensively for their chemopreventive properties. The biological activity of retinoids is acquired through their conversion to retinoic acid (RA). Characterization of endogenous circulating RA concentrations after supplementation with vitamin A over longer time periods has not been done previously. Our investigation was conducted to determine whether vitamin A (retinyl palmitate) supplementation significantly increases circulating RA concentrations of all-trans-, 9-cis-, and 13-cis-RA. Using plasma samples from 41 participants enrolled in a randomized clinical trial of placebo, 25,000, 50,000, or 75,000 IU supplemental retinyl palmitate daily, high-performance liquid chromatography analyses were conducted for concentrations of three RA isomers. Seven plasma samples were analyzed for each participant over a 16-month period. Based on an intention-to-treat analysis, results obtained using linear mixed models showed that supplementation with retinyl palmitate statistically significantly increased concentrations of all three RA isomers from baseline levels. This study suggests that supplementation with retinyl palmitate is an effective means to increase circulating all-trans, 9-cis-, and 13-cis-RA concentrations among humans.

This article has been cited by other articles:

				S. G. Kang, H. W. Lim, O. M. Andrisani, H. E. Broxmeyer, and C. H. Kim Vitamin A Metabolites Induce Gut-Homing FoxP3+ Regulatory T Cells J. Immunol., September 15, 2007; 179(6): 3724 - 3733. [Abstract] [Full Text] [PDF]